Making filibustering senators talk all night gives the public an opportunity to rally, one way or the other. It also, frankly, puts on a show, which will engage the public, restoring interest in government. This is good and we should do it.
The issuance of a temporary injunction barring the NIH from funding human embryonic stem cell research should hardly have come as a surprise. Many of the same plaintiffs and much of the same legal team filed a similar lawsuit a decade earlier.
Tom Harkin was asked to lead a group with the task of crafting the prevention and public-health components of Obama's health-care-reform bill. He spoke with me about his vision for healthcare reform.